Concepedia

Hitoshi Funabashi

HF

Statistics

Publications

15

Citations

660

H-Index

13

Active since

2000

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

Sumitomo Dainippon Pharma (United States)

The University of Osaka

Hitoshi Funabashi is an author at Sumitomo Dainippon Pharma (Japan) specializing in medicine, pharmacology, and toxicology.

Top concepts

Publications per year

2000–2015

15

Publications

15

Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice.

SHOUICHI KADO, Hitoshi Funabashi, S Iwata et al. · PubMed · 2001 · 152 citations

, , +16

GC‐MS‐based metabolomics reveals mechanism of action for hydrazine induced hepatotoxicity in rats

Kiyoko Bando, Takeshi Kunimatsu, Jun Sakai et al. · Journal of Applied Toxicology · 2010 · 97 citations

, , +20

Influences of biofluid sample collection and handling procedures on GC–MS based metabolomic studies

Kiyoko Bando, Rui Kawahara, Takeshi Kunimatsu et al. · Journal of Bioscience and Bioengineering · 2010 · 63 citations

, , +12

Evaluation of ovarian toxicity of mono-(2-ethylhexyl) phthalate (MEHP) using cultured rat ovarian follicles

Hiroshi Inada, Kazuhiro Chihara, Akihito Yamashita et al. · The Journal of Toxicological Sciences · 2012 · 61 citations · Full text

, , +27

Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation

Yumiko Nozaki, Yayoi Honda, Shinji Tsujimoto et al. · Toxicology and Applied Pharmacology · 2014 · 55 citations

, , +8

1–5 of 15